EUVIMEDEUVIMED entdecken
Crossref

Ensuring no patient is lost along the way – a single‐centre experience of the clinical genetics referral pathways for Lynch syndrome

Karim Hussien El-Shakankery iD, Petra Balogh iD, Marianne Grantham, Anna Minicozzi iD, Nikolaos Diamantis iD

Colorectal Disease · 2023

DOI: 10.1111/codi.16496 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Colorectal Disease, 2023. Verfasst von Karim Hussien El-Shakankery und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, University College London Hospitals NHS Foundation Trust, University College Hospital, London, UK. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Hereditary Nonpolyposis, Colorectal Neoplasms, Neoplastic Syndromes, Hereditary. Die Arbeit nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lynch syndrome (LS), caused by heterozygous germline mutation in one of the key mismatch repair (MMR) genes, is the primary cause of inherited colorectal cancer (CRC). LS also increases susceptibility to several other cancers. It is estimated that just 5% of patients with LS are aware of their diagnosis. Therefore, in an attempt to increase the identification of cases within the UK population, the 2017 NICE guidelines recommend offering immunohistochemistry for MMR proteins or microsatellite instability (MSI) testing to all people with CRC when first diagnosed. Following identification of MMR deficiency, eligible patients should be assessed for underlying causes, including potential referral to the genetics service and/or germline LS testing (if appropriate). In our regional centre for CRC, we audited local pathways to identify what proportion of patients are being correctly referred, in line with national guidelines. Reflecting on these results, we highlight our practical concerns by identifying the pitfalls and issues faced with the recommended referral pathway. We also propose possible solutions to improve the efficacy of the system for both referrers and patients. Finally, we discuss the ongoing interventions that national bodies and regional centres are implementing to improve and further streamline this process.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal Neoplasms, Hereditary NonpolyposisColorectal NeoplasmsNeoplastic Syndromes, HereditaryHumansMicrosatellite InstabilityGerm-Line MutationDNA Mismatch Repair

Stichwörter der Autor:innen

colorectal cancerinherited cancer syndromelynch syndromemismatch repair

Autor:innen und Institutionen

  • Department of Oncology, University College London Hospitals NHS Foundation Trust, University College Hospital, London, UK.
  • Department of Pathology, Barts Health NHS Trust, Royal London Hospital, London, UK.
  • Department of General and Colorectal Surgery, Barts Health NHS Trust, Royal London Hospital, London, UK.
  • Department of Oncology, Barts Health NHS Trust, St Bartholomew's Hospital, London, UK.

ORCID-Profile: Karim Hussien El-Shakankery, Petra Balogh, Anna Minicozzi, Nikolaos Diamantis

Zitieren

APA

El-Shakankery, K. H., Balogh, P., Grantham, M., Minicozzi, A., & Diamantis, N. (2023). Ensuring no patient is lost along the way – a single‐centre experience of the clinical genetics referral pathways for Lynch syndrome. Colorectal Disease. https://doi.org/10.1111/codi.16496

Vancouver

El-Shakankery KH, Balogh P, Grantham M, Minicozzi A, Diamantis N. Ensuring no patient is lost along the way – a single‐centre experience of the clinical genetics referral pathways for Lynch syndrome. Colorectal Disease. 2023. doi:10.1111/codi.16496

BibTeX
@article{ElShakankery2023,
  author = {El-Shakankery, Karim Hussien and Balogh, Petra and Grantham, Marianne and Minicozzi, Anna and Diamantis, Nikolaos},
  title = {Ensuring no patient is lost along the way – a single‐centre experience of the clinical genetics referral pathways for Lynch syndrome},
  journal = {Colorectal Disease},
  year = {2023},
  doi = {10.1111/codi.16496}
}
Kostenlos starten →